Annual D&A
$4500.00
-$7700.00-63.11%
December 31, 2023
Summary
- As of March 1, 2025, QLGN annual depreciation & amortization is $4500.00, with the most recent change of -$7700.00 (-63.11%) on December 31, 2023.
- During the last 3 years, QLGN annual D&A has fallen by -$238.60 thousand (-98.15%).
- QLGN annual D&A is now -98.67% below its all-time high of $338.30 thousand, reached on December 31, 2021.
Performance
QLGN Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
N/A
September 30, 2024
Summary
- QLGN quarterly depreciation & amortization is not available.
Performance
QLGN Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
N/A
September 30, 2024
Summary
- QLGN TTM depreciation & amortization is not available.
Performance
QLGN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
QLGN Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -63.1% | - | - |
| 3 y3 years | -98.2% | - | - |
| 5 y5 years | - | - | - |
QLGN Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -98.7% | at low | ||||
| 5 y | 5-year | -98.7% | at low | ||||
| alltime | all time | -98.7% | at low |
Qualigen Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $4500.00(-63.1%) | - | - |
| Dec 2022 | $12.20 K(-96.4%) | $3000.00(-101.8%) | $12.10 K(-87.7%) |
| Sep 2022 | - | -$166.90 K(-281.8%) | $98.30 K(-72.0%) |
| Jun 2022 | - | $91.80 K(+9.0%) | $350.80 K(+2.9%) |
| Mar 2022 | - | $84.20 K(-5.6%) | $340.80 K(+0.8%) |
| Dec 2021 | $338.30 K | $89.20 K(+4.2%) | $338.20 K(+35.8%) |
| Sep 2021 | - | $85.60 K(+4.6%) | $249.00 K(+2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $81.80 K(+0.2%) | $242.40 K(-0.5%) |
| Mar 2021 | - | $81.60 K(+3.3%) | $243.50 K(+50.4%) |
| Dec 2020 | $243.10 K | - | - |
| Sep 2020 | - | $79.00 K(-4.7%) | $161.90 K(+19.2%) |
| Jun 2020 | - | $82.90 K(+56.7%) | $135.80 K(+22.6%) |
| Sep 2019 | - | $52.90 K(-8.6%) | $110.80 K(+91.4%) |
| Jun 2019 | - | $57.90 K | $57.90 K |
FAQ
- What is Qualigen Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Qualigen Therapeutics?
- What is Qualigen Therapeutics annual D&A year-on-year change?
- What is the all time high quarterly D&A for Qualigen Therapeutics?
- What is the all time high TTM D&A for Qualigen Therapeutics?
What is Qualigen Therapeutics annual depreciation & amortization?
The current annual D&A of QLGN is $4500.00
What is the all time high annual D&A for Qualigen Therapeutics?
Qualigen Therapeutics all-time high annual depreciation & amortization is $338.30 K
What is Qualigen Therapeutics annual D&A year-on-year change?
Over the past year, QLGN annual depreciation & amortization has changed by -$7700.00 (-63.11%)
What is the all time high quarterly D&A for Qualigen Therapeutics?
Qualigen Therapeutics all-time high quarterly depreciation & amortization is $91.80 K
What is the all time high TTM D&A for Qualigen Therapeutics?
Qualigen Therapeutics all-time high TTM depreciation & amortization is $350.80 K